Forget 1% from a Cash ISA: I’d pick up 5%+ from these 2 FTSE 100 dividend shares

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver significantly higher income returns than a Cash ISA in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While the interest rates on Cash ISAs may have increased in the last couple of years, the average return is around 1%. That’s well below the rate of inflation, and means that savers are receiving a negative real-terms return on their cash.

By contrast, it is possible to obtain a dividend yield in excess of 5% from these two FTSE 100 shares at the present time.

Although they may experience volatility due to Brexit and the prospect of a global trade war, there is scope for capital growth in the long run. As such, now could be the right time to buy them.

GlaxoSmithKline

GlaxoSmithKline (LSE: GSK) may have failed to raise its dividends per share in recent years, but the stock still has a dividend yield of around 5%. Furthermore, the changes it is making to its business model could improve its long-term earnings growth outlook. This may mean that it is able to raise dividends at a brisk pace.

The company’s decision to offload a number of its consumer healthcare brands in order to focus on its pharmaceutical operations could provide it with greater focus in what is expected to be a growing industry. An ageing world population, growth in the size of the world’s population and urbanisation are expected to lead to increasing demand across the pharmaceutical industry. This could catalyse the company’s financial prospects and increase its ability to pay a higher dividend.

Since GlaxoSmithKline’s financial performance is less correlated to the wider economy than many of its FTSE 100 peers, it could provide a degree of stability during what may prove to be a volatile period for the world economy. As a result, it may deliver capital growth alongside an impressive income stream.

Sainsbury’s

While GlaxoSmithKline may offer defensive appeal, Sainsbury’s (LSE: SBRY) faces an uncertain future. The retailer’s share price has declined by 44% in the last year, with investors apparently concerned about its prospects following the collapse of its proposed merger with Asda.

Although the supermarket sector is experiencing pressure from increasingly price-conscious consumers, the threat of no-frills operators such as Aldi and Lidl and technological change, Sainsbury’s could deliver a relatively appealing income return. The company has a dividend yield of around 6% from a shareholder payout which is covered 1.9 times by profit. And, with the company’s bottom line due to rise by 4% this year, dividend growth may even be on the agenda.

Certainly, Sainsbury’s could continue its recent share price decline. With a price-to-earnings (P/E) ratio of just 8.5, however, the stock appears to have a wide margin of safety. This could mean that it is able to provide capital growth through a stock price recovery alongside its income return. This could lead to a significantly higher total return when compared to the 1% offered on average by Cash ISAs.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

I like Rolls-Royce shares but not the price tag. Here are 2 cheaper alternatives

Rolls-Royce is an incredible company but its shares are richly valued. So are there alternative stocks offering exposure to its…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

Should I buy Lloyds shares before the ISA deadline?

Dr James Fox takes a closer look at Lloyds' shares with the Stocks and Shares ISA deadline fast approaching. The…

Read more »

Middle aged businesswoman using laptop while working from home
Investing Articles

£10,000 invested in Nvidia stock 1 year ago is now worth…

Nvidia stock isn't just important for its shareholders. It's the bellwether for the technology sector and AI. Dr James Fox…

Read more »

Young black woman walking in Central London for shopping
Investing Articles

Down 45% and 33%! Consider these 2 cheap stocks to buy in April

Looking for top stocks to buy at knockdown prices? Royston Wild reckons these FTSE 100 and FTSE 250 value stars…

Read more »

Two people socialising and drinking Guinness.
Investing Articles

Diageo shares just can’t catch a break! Here’s a major new risk

Diageo shares are down 13% since the turn of the year. With pressures rising, is the FTSE 100 stock now…

Read more »

Picture of an easyJet plane taking off.
Investing Articles

£5,000 invested in easyJet shares a month ago is now worth…

easyJet shares are bouncing back as hopes grow for peace in the Middle East. But could this be a false…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

2 bargain-basement income stocks to consider in an ISA

Looking for cheap last-minute shares for a Stocks and Shares ISA? These income stocks could be what investors have been…

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

Prediction: this FTSE AIM stock could soon be one of the top-rated according to these models

What makes for a well-rated stock? In this article, Dr James Fox explains and details why he believes this FTSE…

Read more »